Search Results - Tiansong Xia
-
1
Dosimetric analysis of ultrasound-guided high intensity focused ultrasound ablation for breast fibroadenomas: a retrospective study
Published 2022-12-01Get full textObjective To investigate the factors influencing the sonication dosage and efficiency of ultrasound-guided high intensity focused ultrasound (USgHIFU) for breast fibroadenomas.Materials and Methods Forty-nine patients with 78 breast fibroadenomas who underwent USgHIFU were retrospectively analyzed....
Article -
2
Effects of the Intestinal Microbiome and Metabolites on Neoadjuvant Chemotherapy Efficacy in Breast Cancer
Published 2025-07-01Get full textBackground: Imbalances in the intestinal microbiome are closely associated with the occurrence and development of cancer, and can affect tumorigenesis by influencing the inflammatory response, regulating the immune system, producing specific metabolites, and participating in tumor signaling pathways...
Article -
3
Predicting the sonication energy for focused ultrasound surgery treatment of breast fibroadenomas using machine learning algorithms
Published 2025-12-01Get full textPurpose To establish a predictive model for the sonication energy required for focused ultrasound surgery (FUS) of breast fibroadenomas.Methods This study retrospectively enrolled 87 patients with 154 benign breast tumors treated by FUS in our hospital. Radiomic analysis included 124 tumors from 69...
Article -
4
De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trialResear...
Published 2025-08-01Get full textSummary: Background: Due to the undesirable cumulative toxicity of multiple drugs, de-escalated neoadjuvant chemotherapy strategies are needed for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Pyrotinib, a small-molecule irreversible pan-HER receptor tyrosine kinase inhibi...
Article